When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 & The Gut Brain Axis: A Practitioner's Definitive Review of the Evidence Is BPC157 Legal? WADA, FDA Status, and What You Need to Know